Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-10d49f9tCompleted
Open-label trial of lidocaine in pes anserine syndrome (2 arms), sponsored by IAMSPE. Primary endpoint: Primary endpoint not reported. Started Nov 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-10d49f9t.